Purification of pegylated proteins.
暂无分享,去创建一个
[1] Xiaolan Yang,et al. Site-Specific PEGylation of Therapeutic Proteins via Optimization of Both Accessible Reactive Amino Acid Residues and PEG Derivatives , 2012, BioDrugs.
[2] I. Kaltashov,et al. Structural characterization of protein–polymer conjugates. I. Assessing heterogeneity of a small PEGylated protein and mapping conjugation sites using ion exchange chromatography and top-down tandem mass spectrometry , 2012 .
[3] F. Veronese,et al. The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.
[4] Deqiang Yu,et al. Purification of PEGylated protein using membrane chromatography. , 2010, Journal of pharmaceutical sciences.
[5] Dan Qin,et al. A liquid chromatographic method for determination of the modification degree of proteins: PEGylated arginase as an example. , 2010, Analytical biochemistry.
[6] Simona Jevševar,et al. PEGylation of therapeutic proteins , 2010, Biotechnology journal.
[7] María J. Vicent,et al. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.
[8] Gianfranco Pasut,et al. PEG conjugates in clinical development or use as anticancer agents: an overview. , 2009, Advanced drug delivery reviews.
[9] Jiandu Lei,et al. Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight. , 2009, Journal of biotechnology.
[10] M. Schiefermeier,et al. Correlations between in vitro potency of polyethylene glycol-protein conjugates and their chromatographic behavior. , 2009, Analytical biochemistry.
[11] F. Veronese,et al. PEGylated Protein Drugs: Basic Science and Clinical Applications , 2009 .
[12] A. Zydney,et al. Ultrafiltration of PEGylated proteins: Fouling and concentration polarization effects , 2008 .
[13] David J Brayden,et al. Advances in PEGylation of important biotech molecules: delivery aspects , 2008, Expert opinion on drug delivery.
[14] V. Gaberc-Porekar,et al. Obstacles and pitfalls in the PEGylation of therapeutic proteins. , 2008, Current opinion in drug discovery & development.
[15] Darin L. Lee,et al. Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor. , 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[16] S. Jevševar,et al. Size of Pegylated Protein Conjugates Studied by Various Methods , 2008 .
[17] Shuichi Yamamoto,et al. Effects of protein conformational changes on separation performance in electrostatic interaction chromatography: unfolded proteins and PEGylated proteins. , 2007, Journal of biotechnology.
[18] Byung Kook Lee,et al. Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity. , 2007, Bioconjugate chemistry.
[19] G. Pasut,et al. Polymer-drug conjugation, recent achievements and general strategies , 2007 .
[20] A. Hunter,et al. Comparison of strong anion-exchangers for the purification of a PEGylated protein. , 2007, Journal of chromatography. A.
[21] A. Zydney,et al. Separation of PEGylated α‐Lactalbumin from Unreacted Precursors and Byproducts Using Ultrafiltration , 2007, Biotechnology progress.
[22] A. Zydney,et al. Ultrafiltration characteristics of pegylated proteins , 2006, Biotechnology and bioengineering.
[23] S. Brocchini,et al. Site-specific PEGylation of native disulfide bonds in therapeutic proteins , 2006, Nature chemical biology.
[24] J. V. Alstine,et al. PEG-proteins: Reaction engineering and separation issues , 2006 .
[25] Francesco M Veronese,et al. PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.
[26] M. Grace,et al. Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-α Antiviral and Antiproliferative Activities through the JAK/STAT Signaling Pathway* , 2005, Journal of Biological Chemistry.
[27] R. Tilton,et al. Adsorption of poly(ethylene glycol)-modified lysozyme to silica. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[28] J. V. Van Alstine,et al. Prediction of the viscosity radius and the size exclusion chromatography behavior of PEGylated proteins. , 2004, Bioconjugate chemistry.
[29] Theodore W Randolph,et al. Protein-solute interactions affect the outcome of ultrafiltration/diafiltration operations. , 2004, Journal of pharmaceutical sciences.
[30] Kang-Choon Lee,et al. Capillary electrophoretic characterization of PEGylated human parathyroid hormone with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2004, Analytical biochemistry.
[31] D. C. Wood,et al. Preparative and analytical chromatography of pegylated myelopoietin using monolithic media. , 2004, Journal of chromatography. A.
[32] A. Bernkop‐Schnürch,et al. Development and in vivo evaluation of an oral insulin-PEG delivery system. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[33] B. Domon,et al. Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters. , 2004, Protein expression and purification.
[34] Haeshin Lee,et al. Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity , 2002, Pharmaceutical Research.
[35] Yan-Hui Liu,et al. Carboxyalkylated Histidine Is a pH-Dependent Product of Pegylation with SC-PEG , 2001, Pharmaceutical Research.
[36] Kang-Choon Lee,et al. Isolation, Characterization, and Stability of Positional Isomers of Mono-PEGylated Salmon Calcitonins , 1999, Pharmaceutical Research.
[37] D. Brems,et al. Characterization and Stability of N-terminally PEGylated rhG-CSF , 1996, Pharmaceutical Research.
[38] D. Filpula,et al. Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation. , 2003, Protein engineering.
[39] D. Collen,et al. Clinical development of PEGylated recombinant staphylokinase (PEG-Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction. , 2003, Advanced drug delivery reviews.
[40] Steven W. Martin,et al. Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. , 2003, Advanced drug delivery reviews.
[41] P. Caliceti,et al. PEGylation of growth hormone-releasing hormone (GRF) analogues. , 2003, Advanced drug delivery reviews.
[42] V. Hasırcı,et al. Solid-phase enzyme modification via affinity chromatography. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[43] Siddharth J. Advant,et al. Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse-phase chromatography. , 2003, Biomedical chromatography : BMC.
[44] M. Azarkan,et al. Fractionation and purification of the enzymes stored in the latex of Carica papaya. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[45] Yasuo Yoshioka,et al. Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity , 2003, Nature Biotechnology.
[46] C. Fee. Size-exclusion reaction chromatography (SERC): a new technique for protein PEGylation. , 2003, Biotechnology and bioengineering.
[47] P. K. Smith,et al. Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. , 2003, Bioconjugate chemistry.
[48] Haeshin Lee,et al. A novel method for identifying PEGylation sites of protein using biotinylated PEG derivatives. , 2003, Journal of Pharmacy and Science.
[49] A. Bolognesi,et al. Novel poly(ethylene glycol) derivatives for preparation of ribosome-inactivating protein conjugates. , 2002, Bioconjugate chemistry.
[50] M. Treuheit,et al. Mono-N-terminal poly(ethylene glycol)-protein conjugates. , 2002, Advanced drug delivery reviews.
[51] H. Sato,et al. Enzymatic procedure for site-specific pegylation of proteins. , 2002, Advanced drug delivery reviews.
[52] A. P. Chapman,et al. PEGylated antibodies and antibody fragments for improved therapy: a review. , 2002, Advanced drug delivery reviews.
[53] D. Wyss,et al. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. , 2002, Advanced drug delivery reviews.
[54] S. W. Kim,et al. Effects of PEG conjugation on insulin properties. , 2002, Advanced drug delivery reviews.
[55] S. Pedder,et al. Use of peginterferon alfa-2a (40 KD) (Pegasys) for the treatment of hepatitis C. , 2002, Advanced drug delivery reviews.
[56] M. Bentley,et al. Chemistry for peptide and protein PEGylation. , 2002, Advanced drug delivery reviews.
[57] Tae Gwan Park,et al. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. , 2002, Biomaterials.
[58] P. Esposito,et al. Set-up of large laboratory-scale chromatographic separations of poly(ethylene glycol) derivatives of the growth hormone-releasing factor 1-29 analogue. , 2002, Journal of chromatography. A.
[59] R B Greenwald,et al. PEG drugs: an overview. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[60] F. Veronese. Peptide and protein PEGylation: a review of problems and solutions. , 2001, Biomaterials.
[61] J. Seely,et al. Use of ion-exchange chromatography and hydrophobic interaction chromatography in the preparation and recovery of polyethylene glycol-linked proteins. , 2001, Journal of chromatography. A.
[62] P. Caliceti,et al. New PEGs for peptide and protein modification, suitable for identification of the PEGylation site. , 2001, Bioconjugate chemistry.
[63] Z. Su,et al. Characterization of polyethylene glycol-modified proteins by semi-aqueous capillary electrophoresis. , 2001, Journal of chromatography. A.
[64] P. Caliceti,et al. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine). , 2000, Farmaco.
[65] Z. Shahrokh,et al. Modulating pharmacokinetics of an anti-interleukin-8 F(ab')(2) by amine-specific PEGylation with preserved bioactivity. , 2000, International journal of pharmaceutics.
[66] M. Whitlow,et al. Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds. , 1999, Bioconjugate chemistry.
[67] Mariangela Spitali,et al. Therapeutic antibody fragments with prolonged in vivo half-lives , 1999, Nature Biotechnology.
[68] P. Shaw,et al. Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation. , 1999, Life sciences.
[69] M. Azarkan,et al. Evaluation of the polyethylene glycol–KF–water system in the context of purifying PEG–protein adducts , 1999 .
[70] P. Christakopoulos,et al. Enhancement of pH-stability of a low molecular mass endoglucanase from Fusarium oxysporum by protein pegylation , 1998 .
[71] A. Hartmann,et al. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[72] T. Ueno,et al. Pegylation of proteins and bioactive substances for medical and technical applications , 1998 .
[73] W. Berthold,et al. Polyethylene glycol-conjugated pharmaceutical proteins , 1998 .
[74] Martin Malmsten,et al. Effect of chain density on inhibition of protein adsorption by poly(ethylene glycol) based coatings , 1998 .
[75] R. Hoffman,et al. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy. , 1998, Protein expression and purification.
[76] Samuel Zalipsky,et al. Poly(ethylene glycol): Chemistry and Biological Applications , 1997 .
[77] M. Malmsten,et al. Analytical partitioning of poly(ethylene glycol)-modified proteins. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[78] M. Azarkan,et al. Preliminary characterization of bovine beta-lactoglobulin after its conjugation to polyethylene glycol. , 1997, Biotechnology and bioengineering.
[79] R. Paxton,et al. Structure-Function Studies of Interleukin 15 using Site-specific Mutagenesis, Polyethylene Glycol Conjugation, and Homology Modeling* , 1997, The Journal of Biological Chemistry.
[80] L. Wyns,et al. Thiol pegylation facilitates purification of chymopapain leading to diffraction studies at 1.4 Å resolution , 1996 .
[81] T. Tressel,et al. Preparative electrofocusing for industrial applications. , 1996, Preparative biochemistry & biotechnology.
[82] A A Poot,et al. Proteins involved in the Vroman effect during exposure of human blood plasma to glass and polyethylene. , 1996, Biomaterials.
[83] C. Bona,et al. Purification of antigenized immunoglobulins derivatized with monomethoxypolyethylene glycol. , 1995, Journal of chromatography. A.
[84] S. Shak,et al. Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylation. , 1994, Bioconjugate chemistry.
[85] K. Lund,et al. Analytical gel filtration of dextran for the study of the glomerular barrier function. , 1993, Journal of chromatography.
[86] G. Fortier,et al. Surface modification of horseradish peroxidase with poly(ethylene glycol)s of various molecular masses : preparation of reagents and characterization of horseradish peroxidase-poly(ethylene glycol) adducts , 1993 .
[87] M. Kurfürst. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1992, Analytical biochemistry.
[88] G. Carrea,et al. Circular dichroism and fluorescence of polyethylene glycol‐subtilisin in organic solvents , 1988, FEBS letters.
[89] R. Maskiewicz,et al. Analysis of polyethylene glycol modified superoxide dismutase by chromatographic, electrophoretic, light scattering, chemical and enzymatic methods. , 1988, Chemical & pharmaceutical bulletin.
[90] S. G. Shafer,et al. Cell separation by immunoaffinity partitioning with polyethylene glycol-modified protein A in aqueous polymer two-phase systems. , 1988, Journal of chromatography.
[91] M. Potschka. Universal calibration of gel permeation chromatography and determination of molecular shape in solution. , 1987, Analytical biochemistry.
[92] S. G. Shafer,et al. Immuno-affinity partition of cells in aqueous polymer two-phase systems. , 1986, Journal of chromatography.
[93] Shigenoki Kuga. Pore size distribution analysis of gel substances by size exclusion chromatography , 1981 .
[94] F. Davis,et al. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.
[95] P. Rempp,et al. Étude par chromatographie en phase liquide de polystyrènes linéaires et ramifiés de structures connues , 1966 .